Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents.

Jason SchendPhuong DanielsNeha SananHaig TcheurekdjianRobert Hostoffer

Published in: Allergy & rhinology (Providence, R.I.) (2020)

More studies are necessary to shed light on the immunological response to SARS-CoV-2 and its impact on immunocompromised and immunocompetent and individuals. We describe the course of a patient with COVID-19 in the setting of an acquired humoral deficiency.

Keyphrases

sars cov
coronavirus disease
immune response
respiratory syndrome coronavirus
case report
acute respiratory distress syndrome
smoking cessation